Viatris initiated with an Outperform at Leerink
Upside potential.
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
Upside potential.
What happened, with direct paths to the underlying reporting
Leerink initiates Viatris with an Outperform; target $20 vs current $16.61.
Target: $20
Posted price: $16.61
Analyst firm: Leerink Partners
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.